Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial

Abstract Background Recent cardiovascular outcome trials have shown significant reductions in major cardiovascular (CV) events with glucagon-like peptide (GLP)-1 receptor agonists. Additionally, adjunctive surrogates for cardiovascular risk validated by some studies include arterial stiffness and en...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Antonino Tuttolomondo, Anna Cirrincione, Alessandra Casuccio, Alessandro Del Cuore, Mario Daidone, Tiziana Di Chiara, Domenico Di Raimondo, Vittoriano Della Corte, Carlo Maida, Irene Simonetta, Stefania Scaglione, Antonio Pinto
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-01-01
Edice:	Cardiovascular Diabetology
Témata:	Dulaglutide Vascular health Diabetes
On-line přístup:	https://doi.org/10.1186/s12933-020-01183-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!